Enveda Biosciences

Biotechnology firm focused on drug discovery

Boulder, Colorado, United States

About Enveda Biosciences

Enveda Biosciences focuses on drug discovery by exploring the largely unknown chemical compounds found in nature. With only 5% of these compounds currently understood, Enveda aims to uncover new medicines from this vast chemical space. The company utilizes advanced technologies like machine learning, metabolomics, and robotics to speed up the drug discovery process. Their proprietary platform allows for high-throughput experiments, enabling them to conduct numerous tests quickly and build a comprehensive dataset of small molecules, which are essential for developing new drugs. Enveda primarily serves clients in the healthcare and pharmaceutical sectors, providing them with access to potential new treatments derived from natural resources. The company generates revenue through partnerships, collaborations, and licensing deals for its drug discoveries.

Boulder, ColoradoHeadquarters
2019Year Founded
$342.2MTotal Funding
LATE_VCCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Traditional or Roth 401k matching of 4% (100% of your contributions up to 4% of your annual compensation)
Medical, dental and vision insurance. 100% coverage of employee premiums and 33% coverage of dependents
Unlimited paid time off
Flexible work hours and paid parental leave
Company-wide weeklong break to recharge in addition to 8 observed holidays

Risks

Increased competition from AI-driven drug discovery companies may impact market share.
Reliance on AI models poses risks if data inaccuracies lead to ineffective drugs.
High costs and time of clinical trials could delay drug commercialization.

Differentiation

Enveda uses AI to explore uncharted chemical space for drug discovery.
Their platform conducts high-throughput experiments for rapid drug candidate identification.
Enveda collaborates with tech giants like Microsoft to enhance AI capabilities.

Upsides

Enveda secured $130M funding, indicating strong investor confidence in AI drug discovery.
The Colorado life sciences ecosystem offers partnership and investment opportunities for Enveda.
Experienced executives like Jason Kim and Dr. José Trevejo strengthen Enveda's leadership.